177Lu-zoledronate

N/A

Report date: 2025/12/02 14:07:05

Base Information

Drug Name177Lu-zoledronate
Drug Alias NameLutetium-177 DOTA-ZoledronateITM-41DP-4411
ClassificationRadiation-emitting products > Nuclides > Lutetium > 177LuRadiation-emitting products > Radioactive therapeutic agentRadiation-emitting products > Radionuclide Drug Conjugates +[4] 
Mechanisms of ActionFarnesyl diphosphate synthase inhibitorsPositron-emission tomography enhancers
TargetsFarnesyl diphosphate synthase
Therapy Area/IndicationsBone metastasesOsteosarcoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermany
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesITM Isotope Technologies Munich SE
China Registration ClassN/A

Develop Information

Active CompaniesITM Isotope Technologies Munich SEGrand Pharmaceutical （China） Co Ltd
Inactive CompaniesN/A
Active IndicationsBone metastasesOsteosarcoma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A